Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis.

These results provide the first evidence that NRAS oncogenic variant was identified in DNA samples from KLA patients from not only two affected lesions but also plasma and pleural effusion.